아답토젠 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Adaptogens Market was valued at USD 10.71 billion in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2032. This impressive growth is largely driven by increasing consumer awareness and a growing interest in natural health remedies, particularly those that relieve stress and boost energy levels. As more individuals pursue holistic approaches to health and wellness, adaptogens will emerge as a preferred choice. The influx of innovative start-ups in the market is also playing a significant role in its development. Adaptogens are natural substances that help the body adapt to stressors and promote resilience.

Their popularity is evident across various product forms, including supplements, teas, and snacks. This rising demand aligns with a broader trend toward preventive health measures and the desire for natural ingredients, further fueling market expansion. Adaptogens are gaining traction as essential components of wellness routines, particularly as consumers prioritize mental health and well-being. The market is set for substantial growth, particularly due to the increasing demand for natural products that aid in stress management, mental clarity, and overall wellness.

As consumer preferences shift towards holistic health solutions, the incorporation of adaptogens into daily routines is becoming more common. The expansion of production capabilities and retail outlets is also bolstering industry growth, enhancing the availability of adaptogen products to a broader audience. The ashwagandha segment has emerged as a key player in the adaptogens market, experiencing significant demand due to its well-known stress-relieving and energy-boosting properties. Its popularity is further enhanced by the growing interest in Ayurvedic medicine and holistic health practices, solidifying its position as a primary driver of market growth.

The food and beverage segment is expected to register a robust CAGR of over 6.5% through 2032. The rising trend of functional foods and drinks that offer added health benefits is driving this growth. Consumers increasingly seek natural ingredients in products like herbal teas, energy bars, and beverages designed for stress relief and mental clarity. The drug store channel has accounted for a significant share of the adaptogens market, also projected to grow at over 6.5% CAGR. As more consumers turn to over-the-counter health products, drug stores are becoming key retail outlets for adaptogen supplements.The convenience and trust associated with these retailers are pivotal in driving this segment's growth. The Asia Pacific region accumulates a noteworthy share of the adaptogens market and is expected to grow at over 6.5% CAGR from 2024 to 2032. This growth is fueled by a rich history of traditional medicine in countries like India and China, where adaptogenic herbs have been utilized for centuries. Increasing consumer awareness of the benefits of adaptogens, along with the rise of e-commerce platforms, is making these products more accessible and contributing to a positive market outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Data Mining Sources
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Value chain
  • 3.1.2 Key manufacturers
  • 3.1.3 Go to market routes
  • 3.1.4 Key distributors
    • 3.1.4.1 New distribution channels
  • 3.1.5 Profit margins across the industry
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Market challenges
  • 3.2.3 Market opportunities
    • 3.2.3.1 New markets/applications
    • 3.2.3.2 Growth potential analysis
• 3.3 Raw material landscape
  • 3.3.1 Manufacturing trends
    • 3.3.1.1 Technology evolution
  • 3.3.2 Pricing trend, by Region (USD/Ton)
    • 3.3.2.1 North America
    • 3.3.2.2 Europe
    • 3.3.2.3 Asia Pacific
    • 3.3.2.4 Latin America
    • 3.3.2.5 Middle East & Asia
• 3.4 Regulations & market impact
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Kilo Tons)

• 5.1 Key trends
• 5.2 Ashwagandha
• 5.3 Ginseng
• 5.4 Astragalus
• 5.5 Holy Basil
• 5.6 Rhodiola Rosea
• 5.7 Schisandra
• 5.8 Adaptogenic mushrooms
• 5.9 Others

Chapter 6 Market Size and Forecast, By End-use, 2021-2032 (USD Million, Kilo Tons)

• 6.1 Key trends
• 6.2 Powder
• 6.3 Capsules
• 6.4 Teas & beverages
• 6.5 Others

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

• 7.1 Key trends
• 7.2 Food & Beverage Sources
• 7.3 Dietary & sports supplements
• 7.4 Pharmaceutical
• 7.5 Cosmetics
• 7.6 Animal Feed

Chapter 8 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Million, Kilo Tons)

• 8.1 Key trends
• 8.2 Offline
  • 8.2.1 Supermarket/Hypermarket
  • 8.2.2 Drugstore
  • 8.2.3 Grocery & Convenience Store
• 8.3 Online

Chapter 9 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 Australia
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 MEA
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 South Africa
  • 9.6.4 Rest of MEA

Chapter 10 Company Profiles

• 10.1 REBBL
• 10.2 Organic India
• 10.3 NutraScience Labs
• 10.4 Nutracap Labs
• 10.5 Organika Health Products Inc
• 10.6 PLT Health Solutions
• 10.7 Xi'an Greena Biotech Co. Ltd.
• 10.8 Organic Herb Inc
• 10.9 Xian Yuensun Biological Technology Co. Ltd.
• 10.10 UNO VETCHEM